#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Castleman's disease Congenital generalised lipodystrophy Thalassaemia beta Pneumonia Eosinophilic granulomatosis with polyangiitis Hereditary neuropathic amyloidosis Breast cancer Osteogenesis imperfecta Carcinoid syndrome Hypomagnesaemia Epstein-Barr virus associated lymphoproliferative disorder Activated PI3 kinase delta syndrome Anti-myelin-associated glycoprotein associated polyneuropathy Myocarditis Duchenne muscular dystrophy gene carrier More trials…

    Learn about Rare Diseases

    Cholangitis sclerosing – Treatment Crigler-Najjar syndrome – Diagnostics Loeys-Dietz syndrome Familial amyotrophic lateral sclerosis – Diagnostics Primary mediastinal large B-cell lymphoma – Trials in Disease Isodicentric chromosome 15 syndrome – Trials in Disease Mantle cell lymphoma stage IV – Treatment Kearns-Sayre syndrome – Life with Disease Congenital generalised lipodystrophy – Trials in Disease Crigler-Najjar syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    A24110He Tislelizumab Itraconazole MEGESTROL ACETATE Masupirdine Mezigdomide Belantamab Mafodotin Elinzanetant Cisplatin Alprazolam Tiemonium Methylsulphate Niraparib Tosilate Monohydrate Pelacarsen Wve-006 Hydrocortisone Ph. Eur. Levomethadone Hydrochloride Gad20-209-Fsp-A2 Festuca Rubra Pollen Keto-Valine Calcium Nelivaptan More therapies…

    Learn about Your Condition

    Hypotonia Von Hippel-Lindau disease Skin disorder Chondrosarcoma metastatic Cardiac valve disease Hypochondroplasia Pharyngeal cancer stage III Pancreatitis acute Actinic keratosis Lennox-Gastaut syndrome Caesarean section Crigler-Najjar syndrome Myelofibrosis Endometrial cancer stage IV Organ donor More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Ipilimumab, Nivolumab and Melphalan combination therapy with hepatic perfusion in patients with advanced uveal melanoma that has spread to other organs

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • Melphalan
    • Ipilimumab
    • Nivolumab
    The Netherlands

  • Study on the Effect of Rocuronium Bromide, Sugammadex, and Suxamethonium Chloride for Adults with Respiratory Distress Requiring Emergency Tracheal Intubation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory distress
    Investigated Drugs:
    • Rocuronium Bromide
    • Sugammadex
    • Suxamethonium Chloride
    France

  • Study on Intra-Arterial Thrombolysis with Alteplase for Patients with Acute Ischemic Stroke in the Anterior Circulation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Alteplase
    France

  • Prevention of Infantile Spasms with Vigabatrin in High-Risk Children Under 1 Year Old: A Study for Patients with Tuberous Sclerosis or Large Vascular Brain Injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infantile spasms
    Investigated Drugs:
    • Vigabatrin
    Finland

  • Study on Duloxetine and Benztropine Mesylate for Patients with Severe Functional Somatic Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    • Somatic symptom disorder
    Investigated Drugs:
    • Benztropine Mesylate
    • Duloxetine
    Denmark

  • Study on the Use of Hyperpolarized Pyruvate for MRI Scans in Patients with Pancreatic Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Pyruvic Acid
    Denmark
Previous Page
1 … 366 367 368 369 370 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!